Sign Up
OverviewAPI
The global head and neck cancer treatment market is projected to experience significant growth, driven by factors such as increasing incidence of head and neck cancers, a growing geriatric population, and technological advancements in diagnosis and treatment. The market is segmented by route of administration and therapy, with a growing demand for minimally invasive procedures and oncology-related medical tourism. Leading companies in the market include Amgen Inc., AstraZeneca Plc, Bristol Myers Squibb Co., and Novartis AG.

Ask a question